Avid Bioservices, Inc.
CDMO · NASDAQ
4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | |
|---|---|---|---|---|
| Revenue | $140 | $149 | $120 | $96 |
| % Growth | -6.3% | 24.8% | 24.8% | – |
| Cost of Goods Sold | $133 | $118 | $83 | $67 |
| Gross Profit | $7 | $31 | $37 | $29 |
| % Margin | 5.2% | 21.1% | 30.6% | 30.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $25 | $27 | $21 | $17 |
| SG&A Expenses | $26 | $28 | $21 | $17 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $26 | $28 | $21 | $17 |
| Operating Income | -$19 | -$3 | $11 | $9 |
| % Margin | -13.3% | -1.7% | 9.1% | 9.3% |
| Other Income/Exp. Net | -$8 | -$2 | -$3 | -$1 |
| Pre-Tax Income | -$27 | $2 | $13 | $11 |
| Tax Expense | $114 | $1 | -$115 | $0 |
| Net Income | -$141 | $1 | $128 | $11 |
| % Margin | -100.6% | 0.4% | 106.8% | 11.7% |
| EPS | -2.23 | 0.009 | 2.08 | 0.057 |
| % Growth | -24,877.8% | -99.6% | 3,549.1% | – |
| EPS Diluted | -2.23 | 0.009 | 1.81 | 0.056 |
| Weighted Avg Shares Out | 63 | 62 | 61 | 58 |
| Weighted Avg Shares Out Dil | 63 | 64 | 70 | 59 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $3 | $3 | $1 |
| Depreciation & Amortization | $11 | $7 | $4 | $3 |
| EBITDA | -$11 | $11 | $20 | $16 |
| % Margin | -8.2% | 7.3% | 16.6% | 16.4% |